Brazil vs Cameroon: HIV/AIDS deaths averted by antiretroviral therapy
Brazil
49,655 deaths
in 2024
Cameroon
29,674 deaths
in 2024
Brazil rank
10th
Cameroon rank
12th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Brazil
- Cameroon
How they compare
Brazil currently reports 49,655 deaths against 29,674 deaths in Cameroon, a difference of 19,981 deaths.
That makes Brazil's figure about 1.7 times Cameroon's.
The two have swapped places 3 times across 35 shared years of data; in 1990 it was Cameroon ahead.
Brazil ranks 10th and Cameroon ranks 12th of 157 countries.
Brazil has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Brazil | Cameroon | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 4,547 deaths | 0 deaths | 4,547 deaths | Brazil |
| 2000s | 15,777 deaths | 4,683 deaths | 11,094 deaths | Brazil |
| 2010s | 28,138 deaths | 17,909 deaths | 10,230 deaths | Brazil |
| 2020s | 47,798 deaths | 28,409 deaths | 19,389 deaths | Brazil |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Brazil or Cameroon?
- Brazil, at 49,655 deaths against 29,674 deaths in Cameroon as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Brazil and Cameroon?
- 19,981 deaths, with Brazil ahead.
- How many years of comparable data are there for Brazil and Cameroon?
- 35 years are reported by both, from 1990 to 2024.
- How do Brazil and Cameroon rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Brazil ranks 10th and Cameroon ranks 12th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.